DXB 2.47% 41.5¢ dimerix limited

Ann: Dimerix Presents at ASX Small & Mid-Cap Conference, page-71

  1. 452 Posts.
    lightbulb Created with Sketch. 214
    another smart ar$e I see.
    ///your 1st paper shows you need to reduce proteinuria by at least 50% or to below 1g /day in the 1st year to be protective long term
    ///your 2nd paper says reducing proteinuria by at least 40% and to below 1.5 g/ day gives better long term outcome in fsg
    ///your 3rd paper does have some charts at the end with GFR slope change by every 10% drop in proteinuria, but they don't correlate this with any quantifiable survival outcome or time to end stage kidney disease.
    ....so I ask again, the SPECIFIC claim "10% proteinuria decline gives 5-6 extra years life" ,on what is that based, where is that stated?
    if anything your 1st 2 papers highlight the relative weakness of the dimx drug because it hasn't demonstrated anything like those sorts of proteinuria reductions, has it?
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
41.5¢
Change
0.010(2.47%)
Mkt cap ! $228.5M
Open High Low Value Volume
41.0¢ 43.0¢ 39.0¢ $1.884M 4.545M

Buyers (Bids)

No. Vol. Price($)
3 57256 41.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 21505 1
View Market Depth
Last trade - 16.10pm 07/08/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.